Diagnoly, a French DeepTech company specialising in prenatal imaging, has launched its Fetoly application on iOS, extending the AI-powered fetal ultrasound assistant to iPad for the first time. The tool is already deployed in more than 20 countries and connects directly to existing ultrasound systems without requiring additional hardware.
The release follows Diagnoly’s recent collaboration announcement with GE HealthCare and reflects growing demand for AI tools that can operate alongside established clinical equipment rather than replacing it.
How Fetoly works in practice
Fetoly works by continuously analysing the ultrasound video stream during fetal examinations. It verifies examination completeness by assessing which anatomical structures have been observed and flags suspicious findings through automated measurements. The clinician retains full control of clinical decisions throughout.
Bringing Fetoly to iOS is an important step in our mission to make advanced fetal ultrasound AI available in routine clinical practice worldwide. Our objective is simple: provide healthcare professionals a second set of expert eyes in real-time, directly during the examination.
A notable technical choice underpins the approach: Fetoly runs locally on the device rather than in the cloud. This sidesteps the patient data governance concerns that have slowed adoption of cloud-based medical AI tools in many jurisdictions, and means the application works without a network connection during scans.
New diagnostic capabilities
The latest version (2026.02.25) adds automated ratios for detecting ventriculomegaly, corpus callosum abnormalities, and total anomalous pulmonary venous return (TAPVR). These are conditions where early detection during routine scans can materially alter patient outcomes.
Fetal ultrasound remains one of the most operator-dependent imaging procedures in medicine, with scan quality varying considerably by practitioner experience and clinical setting. Diagnoly positions Fetoly as a standardisation tool: consistent AI analysis applied to every scan, regardless of who is holding the probe.
The app is available on the App Store and Google Play Store.
